Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Atopic Dermatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03556592
What this trial is testing

Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4

Who this might be right for
Atopic Dermatitis
LEO Pharma 40
Large-scale testing (Phase 3)Study completedNCT00351052
What this trial is testing

Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Novartis 184
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07175233
What this trial is testing

Evaluate the Efficacy, Safety of SIM0278 in Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Jiangsu Simcere Pharmaceutical Co., Ltd. 184
Large-scale testing (Phase 3)Study completedNCT06004050
What this trial is testing

A Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Delgocitinib Cream in Chinese Adults and Adolescents With Moderate to Severe Chronic Hand Eczema

Who this might be right for
Chronic Hand Eczema
LEO Pharma 362
Not applicableLooking for participantsNCT05819463
What this trial is testing

Treatment and Medical Care of Patients With Moderate-to-severe Atopic Dermatitis - TREATswitzerland

Who this might be right for
Atopic Dermatitis
Swiss Society of Dermatology and Venereology 700
Testing effectiveness (Phase 2)Study completedNCT04444752
What this trial is testing

Assess the Efficacy and Safety of CBP-201 in Adult Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Moderate-to-severe Atopic Dermatitis
Connect Biopharm LLC 226
Testing effectiveness (Phase 2)Looking for participantsNCT07193589
What this trial is testing

A Phase II Clinical Study Evaluating of ZL-82 Tablets in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Chengdu Zenitar Biomedical Technology Co., Ltd 111
Early research (Phase 1)Study completedNCT06553209
What this trial is testing

Study of CM512 in Healthy Subjects and Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Keymed Biosciences Co.Ltd 110
Testing effectiveness (Phase 2)Looking for participantsNCT07599813
What this trial is testing

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic DermatitisAtopicDermatitis+5 more
Apollo Therapeutics Ltd 280
Testing effectiveness (Phase 2)Study completedNCT07103174
What this trial is testing

MG-K10 Humanized Monoclonal Antibody Injection in Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Shanghai Mabgeek Biotech.Co.Ltd 60
Post-approval studies (Phase 4)Study completedNCT00925730
What this trial is testing

Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under Occlusion

Who this might be right for
Atopic Dermatitis
Novartis 20
Testing effectiveness (Phase 2)Study completedNCT01785602
What this trial is testing

Efficacy and Safety Study of QAW039 in the Treatment of Patients With Moderate to Severe Atopic Dermatitis.

Who this might be right for
Atopic Dermatitis
Novartis Pharmaceuticals 103
Post-approval studies (Phase 4)Study completedNCT01077882
What this trial is testing

Analysis of the Quality of Life, the Clinical Effectiveness and Cost-effectiveness of a Novel Educational Programme in Patients With Psoriasis and Atopic Dermatitis

Who this might be right for
PsoriasisAtopic Dermatitis
University Hospital, Ghent 50
Large-scale testing (Phase 3)Study completedNCT04626297
What this trial is testing

Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA)

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 254
Not applicableWithdrawnNCT04761978
What this trial is testing

Efficacy and Tolerance of JAK Inhibitors in ATU for Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
University Hospital, Lille
Large-scale testing (Phase 3)Looking for participantsNCT06807281
What this trial is testing

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

Who this might be right for
Atopic Dermatitis
Pfizer 500
Post-approval studies (Phase 4)Study completedNCT00445081
What this trial is testing

Prednisolone vs. Ciclosporine in Severe Atopic Eczema

Who this might be right for
Atopic Dermatitis
Technische Universität Dresden 66
Post-approval studies (Phase 4)UnknownNCT03461302
What this trial is testing

Efficacy of Topical Coal Tar in Children With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Radboud University Medical Center 80
Testing effectiveness (Phase 2)Study completedNCT07712536
What this trial is testing

Phase IIa Study of Pharmacokinetics, Safety and Efficacy of QY201 Tablets in Adolescent Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Adolescent Participants With Moderate to Severe Atopic Dermatitis (AD)
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. 24
Large-scale testing (Phase 3)Looking for participantsNCT06461897
What this trial is testing

Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AbbVie 675
Next Page